$118M sweet spot round size
Most of their 18 investments are in rounds between $100M and $168M
2004
COMPASS Pathways raised $125M on August 16, 2023
Investors: Vivo Capital, Soleus Capital Management, L.P., Laurion Capital Management LP, RA Capital Management, L.P., Surveyor Capital, Logos Global Management, LP, TCG X, Armistice Capital LLC and Partner Fund Management
Boundless Bio raised $100M on May 16, 2023
Investors: Nextech Invest, Sectoral Asset Management, Redmile Group, Leaps by Bayer, Surveyor Capital, Vertex Ventures HC, Logos Global Management, LP, RA Capital Management, L.P., Wellington Management and Partner Fund Management
Escient Pharmaceuticals raised $120M on November 28, 2022
Investors: Osage University Partners (OUP), Redmile Group, The Column Group, Sanofi Ventures, Avego Healthcare Capital, The Eleven Fund and Partner Fund Management
Metagenomi raised $175M on January 25, 2022
Investors: Pura Vida Investments, Millennium Partners, Surveyor Capital, YAYA Capital, Novo Holdings, Leaps by Bayer, Moderna, Marshall Wace, RA Capital Management, L.P. and Partner Fund Management
Apella Technology raised $21M on December 20, 2021
Investors: Operator Partners, Casdin Capital, LLC, Twine Ventures, Upside Partnership, Vensana Capital and Partner Fund Management
Lark Health® raised $100M on October 13, 2021
Investors: King River Capital, IPD Capital, LLC, Olive Tree Capital and Partner Fund Management
Undisclosed raised $130M on September 16, 2021
Investors: ProAssurance, Optum Ventures, IPF Partners, Intel Capital, surgical.ai, Relyens, Lauxera Capital Partners, Vesalius Biocapital and Partner Fund Management
Turnstone Biologics raised $80M on July 14, 2021
Investors: Sectoral Asset Management, Takeda UK Limited, OrbiMed Advisors, Ridgeback Capital Management LLC, Point72 Asset Management, Teralys Capital, Surveyor Capital, Versant Ventures, Sixty Degree Capital and Partner Fund Management
CMR Surgical raised $591M on June 28, 2021
Investors: RPMI Railpen, Watrium AS, Chimera Partners Limited, Cambridge Innovation Capital plc, LGT Private Banking, Tencent, SoftBank Investment Advisers and Partner Fund Management
NiKang Therapeutics Inc. raised $200M on May 26, 2021
Investors: Wellington Management, Surveyor Capital, Samsara BioCapital, Perceptive Advisors, RTW Investments, LP, RA Capital Management, L.P., 经纬创投(北京)投资管理顾问有限公司, Octagon Capital Advisors and Partner Fund Management